Patients with obesity-related heart failure who took semaglutide 2.4 mg weekly lost substantial weight and reported fewer ...

A meta-analysis of 10 randomized controlled trials involving more than 23,000 participants, presented at the International ...

A new robotic heart can recreate different stages of heart failure, potentially giving researchers a new way to test ...

Right ventricular dysfunction (RVD) is prevalent in 41.7 percent of patients with heart failure with preserved ejection fraction (HFpEF).

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Phenotyping in HFpEF aids in tailoring therapies, addressing comorbidities, and improving patient outcomes. Artificial intelligence models effectively diagnose HFpEF and predict mortality, enhancing ...

Starting a statin may improve outcomes in patients with heart failure with preserved ejection fraction (HFpEF) who are initially free from atherosclerotic cardiovascular disease (ASCVD), according to ...

Serial KCCQ-TSS decline emerged as the most prominent pre-event signal for sudden death, contrasting with improving symptoms and biomarkers among survivors over the same interval. Trajectories before ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Jennifer E. Ho, MD ...

BOSTON, MA—Tirzepatide improves outcomes in patients with heart failure with preserved ejection fraction (HFpEF) and obesity, no matter how much excess body weight they have, according to an analysis ...